KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Guy Sips ... (+2)
  • Guy Sips
  • Michiel Declercq
Guy Sips
  • Guy Sips

Amoéba Brazil: an attractive growth market for biocontrol – AXPERA sho...

Amoéba has conducted, in partnership with Koppert, an extensive programme of field trials in Brazil to assess the potential of its AXPERA biofungicide technology on several key crops, such as soya and orange trees, of which Brazil is the world's leading producer. We maintain our Buy and € 1.4 Target Price.

Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Thibault Leneeuw
  • Wim Lewi
Thibault Leneeuw
  • Thibault Leneeuw

ASML Strong AI momentum, memory cyclicality and market share risks

Over the past months, the strength of the AI cycle has been remarkably strong, reflected in significant increases in hyperscalers' CapEx, which have supported higher revenues for semiconductor manufacturers and driven incremental investments. Memory, in particular, benefitted from the strong increase in demand. We expect a strong year for ASML in 2026, but remain cautious on 2027 and beyond, mainly due to revenue and CapEx cyclicality at memory players and market-share expectations for ASML post...

Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Thomas Couvreur
Alan Vandenberghe ... (+2)
  • Alan Vandenberghe
  • Thomas Couvreur

RISING INTEREST RATES: FEAR OR PRAISE? Thematic Report

Rising interest rates are becoming a hot topic, triggered by a significant uptick in US 10-year treasury yields through February and March. In this note we revisit this topic from several angles. We dig into the empirical side of what we can reasonably expect from the market as a whole when interest rates start to rise. Secondly we review our coverage, putting forward a number of impacted sectors and stocks.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch